News Image

Citius Oncology Expands LYMPHIRâ„¢ Distribution to Turkey and Middle East Countries Through Exclusive Agreement with Er-Kim

Provided By PR Newswire

Last update: Dec 4, 2025

Partnership expands access to LYMPHIR for patients with cutaneous T-cell lymphoma across Turkey, Bahrain, Qatar, Oman, Kuwait, Saudi Arabia, and the UAE

Read more at prnewswire.com

CITIUS PHARMACEUTICALS INC

NASDAQ:CTXR (12/9/2025, 7:12:08 PM)

After market: 1.1184 -0.08 (-6.8%)

1.2

+0.08 (+7.14%)


CITIUS ONCOLOGY INC

NASDAQ:CTOR (12/9/2025, 6:51:50 PM)

After market: 1.18 +0.02 (+1.72%)

1.16

+0.07 (+6.42%)



Find more stocks in the Stock Screener

Follow ChartMill for more